Zevra Therapeutics, Inc. ZVRA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $124.22M+49.2% | $83.23M+136% | $35.33M+1,236% | $2.64M+103% | -$91.99M+12.8% | ||
| $2.77M-31.6% | $4.05M-24.1% | $5.34M-18.7% | $6.57M+1.4% | $6.48M+1.4% | ||
| $12.62M-0.1% | $12.63M+2.2% | $12.37M-21.4% | $15.73M-1.1% | $15.9M+6.7% | ||
| —— | —— | —— | -$46.21M+25.1% | -$61.72M+11.4% | ||
| $802K-7.4% | $866K0.0% | $866K+178% | $312K+215% | $99K— | ||
| —— | —— | —— | -$14.35M+45.7% | -$26.41M-19.2% | ||
| $60.09M— | $0— | —— | —— | —— | ||
| -$42.35M-451% | $12.06M+17.0% | $10.31M-85.0% | $68.55M-16.9% | $82.5M+0.5% | ||
| $58.26M+104% | $28.62M+7,055% | $400K-95.3% | $8.45M+253% | -$5.51M+40.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Zevra Therapeutics, Inc. generate?
- Zevra Therapeutics, Inc. (ZVRA) generated -$21.9M in operating cash flow over the trailing twelve months.
- What is Zevra Therapeutics, Inc.'s free cash flow?
- After $802.0K of capital expenditures, Zevra Therapeutics, Inc.'s free cash flow was -$22.3M over the trailing twelve months, up 68.0% year over year.
- Where does Zevra Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Zevra Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
